Symptomatic treatment in multiple sclerosis.
The increased awareness of the impact and complexity of management of symptoms in multiple sclerosis has resulted in advances in the understanding of their mechanisms, and in improvements in their measurement and management. It has also highlighted the paucity of evidence-based practice in this area and the need to develop agreed and comprehensive management strategies.
Thompson
A J
AJ
Institute of Neurology, London, UK. a.thompson@ion.ucl.ac.uk
D000928:Antidepressive Agents / Q000627:therapeutic use; D003072:Cognition Disorders / Q000628:therapy; D005221:Fatigue / Q000188:drug therapy; D006801:Humans; D009069:Movement Disorders / Q000628:therapy; D009103:Multiple Sclerosis / Q000628:therapy*; D010146:Pain / Q000188:drug therapy; D001745:Urinary Bladder Diseases / Q000628:therapy
D000928:Antidepressive Agents